Abstract:Purpose: Activation of bone morphogenetic protein (BMP) 4 signaling promotes the survival of retinal ganglion cell (RGC) after acute injury. Chordin-like 1 (CHRDL1) is an endogenous BMP antagonist. In this study, we researched whether CHRDL1 was involved in BMP4 signaling and regulation of RGC degeneration in a mouse model of glaucoma. Methods: Magnetic micmbeads were intracameral injected to induce experimental glaucoma in a mouse model. A recombinant adeno-associated virus (rAAV) system was designed for overexpression of BMP4 or CHRDL1 in mouse retina. Immunohistochemistry and hematoxylin-eosin (HE) stains were performed to identify changes in retinal morphology. Electroretinogram (ERG) recordings were used to assess changes in visual function. Results: The mRNA expression levels of Bmp4 and its downstream BMPRIa, small mothers against decapentaplegic 1 (Smadl), were significantly upregulated in retinas with glaucoma. RGC survival was significantly enhanced in the beads + AAV-BMP4 group and significantly reduced in the beads + AAV-CHRDL1 group, compared with the beads + AAV-EGFP group. Similar results were observed in retinal explant culture in vitro. Consistent with these findings, the photopic negative response (PhNR)responses in ERG, which indicate RGC function, were restored in mice overexpressing BMP4, whereas a-wave and b-wave responses were not. Activation of CHRLD1 inhibited Smad1/5/8 phosphorylation and exacerbated RGC damage. The expression of Glial fibrillary acidic protein (GFAP) was decreased significantly in beads + AAV-BMP4 group. Conclusions: BMP4 promoted RGC survival and visual function in an experimental glaucoma model. Activation of CHRDL1 exaggerated RGC degeneration by inhibiting the BMP4/Smad1/5/8 pathway. The mechanism of BMP4/ Smad1/5/8 pathway may be related to the inhibition of glial cell activation. Our studies suggested that BMP4 and CHRLD1 might serve as therapeutic targets in glaucoma.

Research progress on the regulation of BMP4 on ocular cells

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

BMP Signaling in the Development and Regeneration of Cranium Bones and Maintenance of Calvarial Stem Cells.

The role of bone morphogenetic protein 4 in corneal injury repair

Regulation of bone morphogenetic protein 4 on epithelial tissue

Inhibitory Effect of Bone Morphogenetic Protein 4 in Retinal Pigment Epithelial-Mesenchymal Transition

Protective Effect and Mechanism of Bone Morphogenetic Protein-4 on Apoptosis of Human Lens Epithelium Cells under Oxidative Stress.

The effect of bone morphogenetic proteins in fibrotic diseases in ophthalmology

Overexpression of BMP4 Protects Retinal Ganglion Cells in a Mouse Model of Experimental Glaucoma

Role and Mechanism of BMP4 in Regenerative Medicine and Tissue Engineering

Eye Development and BMP Signaling Pathway

[Progress in the Study on Bone Morphogenetic Protein 2/4 in Central Nervous System].

Role and mechanism of BMP4 in bone, craniofacial, and tooth development

BMP4 Inhibits Corneal Neovascularization by Interfering with Tip Cells in Angiogenesis.

BMP—4 Induced Proliferation and Oriented Differentiation of Rat Hepatic Oval Cells into Hepatocytes

Role of ID Proteins in BMP4 Inhibition of Profibrotic Effects of TGF-β2 in Human TM Cells

The Role of Bone Morphogenetic Protein 4 in Lung Diseases

BMP-4 and BMP-7 Inhibit EMT in a Model of Anterior Subcapsular Cataract in Part by Regulating the Notch Signaling Pathway.

Chrdl1-mediated BMP4 inhibition disrupts the balance between retinal neurons and Müller Glia

The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease

BMP-7: Therapeutic Target for Ocular Fibrotic Disorders